Longevity Radar — September 27, 2026: banks move towards managing the entire post-60 life, Indonesia reforms retirement finance before its demographic shift, and new evidence challenges parts of the anti-ageing supplement market

The most relevant developments on Sunday, September 27, 2026 show the Longevity Economy entering a more mature phase. South Korea is turning financial institutions into integrated platforms spanning wealth, housing, healthcare and long-term care; Indonesia is confronting a retirement system that covers only a small portion of its future older population; new npj Aging research is separating biomarker changes from clinically proven health benefits; vascular brain health is moving closer to dementia prevention; and Senior Living operators are warning that workforce and operational capacity may become a bigger constraint than physical supply.

South Korea turns financial institutions into lifetime longevity platforms

A report published today, September 27, shows Korean banks and insurers rapidly expanding beyond pensions and wealth management into care, housing, health, inheritance and AgeTech. South Korea’s 65+ population is expected to rise from approximately 10.51 million in 2025 to 12.98 million by 2030. Older households are also becoming increasingly important asset holders: people aged 65+ held approximately KRW2,871 trillion in net assets in 2022, around 27% of household net assets, with estimates suggesting KRW6,433 trillion and roughly 35% by 2030. Korea’s senior market could reach around KRW215 trillion by 2030.

KB Financial has already created centres combining financial advisers, tax specialists, nurses providing care consultations and an AgeTech laboratory where clients can experience care facilities, mobility devices and fall-monitoring technology. Shinhan, Hana, Woori and NongHyup are developing similar ecosystems.

For executives, the lesson is clear: longevity finance is moving from helping customers accumulate assets to helping them deploy those assets across thirty years of retirement, housing and care.

Indonesia faces the financial mathematics of longer lives

Indonesia’s older population now represents roughly 11.97% of the country and is projected to reach 20.31% by 2045. Pension assets totalled around Rp1,699 trillion — US$106.85 billion — by July 2026, but active pension participation remains close to 5%. Retirement-income replacement rates are estimated at only 15%-20%.

The financial regulator OJK is opening voluntary pension funds to independent asset managers and preparing tightly controlled access to overseas investment to improve diversification. At the same time, Indonesia is consolidating government and civil-society data for its national review of the Madrid International Plan of Action on Ageing, identifying policy gaps and priorities for older citizens.

For banks, insurers and asset managers, emerging economies may become one of the largest future markets for Financial Longevity.

A 24-week NMN trial provides a useful reality check for longevity supplements

A randomized, double-blind, placebo-controlled trial published in npj Aging on September 25 gave healthy adults aged 65+ 1,250 mg of NMN daily for 24 weeks. Supplementation clearly increased circulating NAD+ and related metabolites and was generally well tolerated.

But raising the biomarker did not translate into supported improvements in the primary auditory endpoint or physical-performance outcomes. Exploratory changes in body composition and lipid-related measures did not survive correction for multiple testing.

For longevity businesses, this distinction matters enormously: biological target engagement is not the same as proven healthspan improvement. The market is likely to demand increasingly strong evidence around function, disease prevention and disability rather than biomarker movement alone.

Biological-age clocks do not all appear to measure the same thing

Another npj Aging paper published on September 25 analysed 4,018 Health and Retirement Study participants using machine-learning models across demographic, behavioural, socioeconomic, clinical and genetic domains.

Predictability varied markedly between epigenetic clocks. GrimAge produced the strongest model performance, followed by DunedinPoAm, while several other clocks showed relatively little predictive signal in this analysis. Health behaviours — especially smoking-related variables — accounted for much of the signal.

For longevity clinics and healthtech firms, the implication is that simply reporting a single “biological age” number may become increasingly difficult to defend. The future market will need to show what each clock measures and whether changing it predicts better real-world outcomes.

Silent brain infarctions strengthen the link between vascular prevention and brain longevity

A Hypertension Research study published September 25 examined 652 independent community-dwelling older adults, average age 69.7, without apparent dementia. MRI identified silent brain infarctions in 10% of participants.

After adjustment, silent infarction was associated with roughly twice the odds of executive dysfunction, while global cognitive impairment was more closely associated with hippocampal atrophy. The study is cross-sectional, so causality cannot be inferred, but it supports the growing view that vascular risk management may play an important role in cognitive ageing.

For healthcare organisations, brain health is therefore becoming increasingly inseparable from blood pressure, metabolism, cardiovascular prevention and physical activity.

Senior Living faces a workforce and operational-capacity problem

A survey of more than 500 Senior Living professionals found that 81% report increasing resident acuity, while only 12% describe staffing as consistently sufficient. More than 43% believe the industry is not ready for incoming demographic demand and 83.9% say community operations have become more complex over the past two years.

Technology fragmentation is also a problem: 44.1% identified switching between systems as their main digital frustration. Yet roughly 63% of executives describe themselves as either very open or cautiously open to AI. Asked how they would use an hour returned to them by technology, executives most often chose resident engagement and direct care.

For operators, the most valuable AI may therefore be technology that reduces documentation, connects systems, predicts deterioration and returns human time to residents, rather than attempting to replace caregivers.

The key takeaway

The common thread on September 27 is convergence.

Finance is converging with care. Pension policy is converging with demographic strategy. Biomarkers are being forced to converge with real clinical outcomes. Cardiovascular health is converging with cognitive health. Senior Living is converging with AI, data and workforce strategy.

For executives and organisations, longevity should no longer be viewed simply as an “older consumer” category. It is becoming a horizontal transformation of healthcare, financial services, Real Estate, technology, employment, insurance, travel, fitness and consumer markets.

The companies that understand how to accompany people across multiple stages of a 50-to-100-year life may capture far more value than those selling one isolated product to an age-defined segment.